Meda Pharmaceuticals has announced a new nasal spray “Dymista” that contains both a steroid and an anti-histamine active ingredient. Why is this significant? It’s because it’s the first and only one to do so. Of course, it’s not available yet until the FDA approves it, but at least it has shown effectiveness in Phase 3 clinical trials.
At this time, nasal sprays as it relates to nasal allergies come in two separate flavors:
This new combo nasal spray “Dymista” contains Read more »
*This blog post was originally published at Fauquier ENT Blog*